Home/Pipeline/ChondroStem™ Autologous

ChondroStem™ Autologous

Knee and Hip Osteoarthritis

Phase 3Active

Key Facts

Indication
Knee and Hip Osteoarthritis
Phase
Phase 3
Status
Active
Company

About Cell Technologies

Regenerative stem‑cell therapies for OA and spinal disease, with FDA/Health Canada approval.

View full company profile